Compile Data Set for Download or QSAR
Report error Found 143 Enz. Inhib. hit(s) with all data for entry = 6979
TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163169(US9062045, 8)
Affinity DataIC50: 1nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163174(US9062045, 13)
Affinity DataIC50: 1nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163201(US9062045, 40)
Affinity DataIC50: 1nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163205(US9062045, 44)
Affinity DataIC50: 1nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163213(US9062045, 53)
Affinity DataIC50: 1nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163224(US9062045, 67)
Affinity DataIC50: 1nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163215(US9062045, 55)
Affinity DataIC50: 1.30nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163164(US9062045, 3)
Affinity DataIC50: 2nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163175(US9062045, 14)
Affinity DataIC50: 2nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163180(US9062045, 21)
Affinity DataIC50: 2nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163183(US9062045, 24)
Affinity DataIC50: 2nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163189(US9062045, 30)
Affinity DataIC50: 2nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163198(US9062045, 37)
Affinity DataIC50: 2nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163199(US9062045, 38)
Affinity DataIC50: 2nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163204(US9062045, 43)
Affinity DataIC50: 2nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163212(US9062045, 52)
Affinity DataIC50: 2nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163217(US9062045, 57)
Affinity DataIC50: 2nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163234(US9062045, 78)
Affinity DataIC50: 2nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163168(US9062045, 7)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163171(US9062045, 10)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163177(US9062045, 17)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163186(US9062045, 27)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163190(US9062045, 31)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163209(US9062045, 49)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163218(US9062045, 58)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163219(US9062045, 59)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163226(US9062045, 69)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163227(US9062045, 70)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163244(US9062045, Reference Example No. 63)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163245(US9062045, Reference Example No. 66)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163243(US9062045, Comparator No. 1 (JNJ-38877605))
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163172(US9062045, 11)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163173(US9062045, 12)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163176(US9062045, 15)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163184(US9062045, 25)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163188(US9062045, 29)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163192(US9062045, 33)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163194(US9062045, 35)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163196(US9062045, 35B)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163197(US9062045, 36)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163203(US9062045, 42)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163210(US9062045, 50)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163211(US9062045, 51)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163220(US9062045, 60)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163221(US9062045, 61)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163230(US9062045, 74)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM50396934(CHEMBL2170804 | CHEMBL2001019 | US9062045, Compara...)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163163(US9062045, 2)
Affinity DataIC50: 5nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163195(US9062045, 35A)
Affinity DataIC50: 5nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM163207(US9062045, 47)
Affinity DataIC50: 5nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

Displayed 1 to 50 (of 143 total ) | Next | Last >>
Jump to: